Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
IPN.PAthis companyIpsen S.A.	€163.50	22.16×	2.29×	2.7×	8.42×	79.2%	70.6%	20.3%	12.1%	10.3%	10.4%	10.4%	0.2×	-0.6×	20.67×	1.96×	1.2%	6	4.23	3	B+
ABVX.PAAbivax S.A.	€77.30	-24.93×	18.39×	0×	-31.6×	-91.3%	0.0%	0.0%	0.0%	-73.8%	-48.0%	-1.9%	0.07×	1.94×	-8.79×	8.75×	0.0%	3	37.94	2	C
ALCLS.PACellectis S.A.	€1.05	-7.05×	6.52×	6.52×	-24.8×	-443.6%	72.5%	-55.3%	-92.7%	-92.7%	-19.9%	-8.9%	1.2×	-1.38×	-4.98×	1.62×	0.0%	2	-1.71	1	D+
ALTHX.PATHX Pharma	€3.33	-9.73×	14.83×	0×	-3.12×	-105.8%	0.0%	0.0%	0.0%	-151.2%	-120.3%	-3.2%	1.45×	-0.21×	-102.85×	1.55×	0.0%	5	0.02	1	D+
ALALTME.PATME Pharma N.V.	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
ALVIO.PAValerio Therapeutics S.A.	€0.49	-4.35×	10.27×	8.28×	51.4×	-135.2%	67.1%	-21.4%	-190.4%	-236.0%	-5.5%	2.4%	3.67×	12.09×	-1.96×	0.76×	0.0%	6	5.8	2	C
Peer median	—	-8.39×	12.55×	3.26×	-13.96×	-120.5%	33.5%	-10.7%	-46.3%	-121.9%	-33.9%	-2.6%	1.32×	0.87×	-6.88×	1.59×	0.0%	4	2.91	2	—